EMVision Medical Devices Ltd Share Price

Equities

EMV

AU0000028375

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 07:10:44 26/04/2024 BST 5-day change 1st Jan Change
2.15 AUD -2.27% Intraday chart for EMVision Medical Devices Ltd -3.15% +26.84%

Financials

Sales 2022 4.36M 2.85M 228M Sales 2023 6.97M 4.55M 365M Capitalization 91.16M 59.55M 4.77B
Net income 2022 -6M -3.92M -314M Net income 2023 -3M -1.96M -157M EV / Sales 2022 25.3 x
Net cash position 2022 6.06M 3.96M 317M Net cash position 2023 6.93M 4.53M 362M EV / Sales 2023 12.1 x
P/E ratio 2022
-18.5 x
P/E ratio 2023
-23.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 66.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.27%
1 week-3.15%
Current month-16.34%
1 month-14.68%
3 months+2.38%
6 months+38.71%
Current year+26.84%
More quotes
1 week
2.13
Extreme 2.13
2.28
1 month
2.13
Extreme 2.13
2.65
Current year
1.75
Extreme 1.75
2.72
1 year
1.13
Extreme 1.13
2.72
3 years
1.13
Extreme 1.13
3.42
5 years
0.36
Extreme 0.36
4.20
10 years
0.28
Extreme 0.28
4.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 31/12/19
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 78 28/09/20
Director/Board Member - 31/03/18
Director/Board Member - 30/06/18
More insiders
Date Price Change Volume
26/04/24 2.15 -2.27% 151,387
24/04/24 2.2 -2.65% 59,916
23/04/24 2.26 +0.89% 39,644
22/04/24 2.24 +0.90% 51,698
19/04/24 2.22 -3.48% 71,076

Delayed Quote Australian S.E., April 26, 2024 at 07:10 am

More quotes
EMVision Medical Devices Limited is an Australia-based medical device company developing an approach to looking inside the human body. The Company is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The Company is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Company’s product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.
More about the company

Annual profits - Rate of surprise